Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot study

Area of Science:

• Oncology
• Immunology
• Urology

Background:

• Cytokines play a crucial role in cancer development and the tumor microenvironment.
• Understanding cytokine roles in bladder cancer is essential for diagnosis and treatment.
• The specific cytokine profile in bladder cancer remains incompletely understood.

Purpose of the Study:

• To investigate the potential of specific urinary cytokines as biomarkers for urothelial carcinoma.
• To determine if IL-6 and IL-8 concentrations in urine can differentiate between cancer patients and controls.

Main Methods:

• Urine samples were collected from patients with urothelial carcinoma and benign conditions.
• Urinary concentrations of IL-6, IL-8 (CXCL8), CCL18, and CXCL9 were measured using enzyme immunoassays.
• Cytokine levels were normalized to urinary creatinine.

Main Results:

• Significantly higher concentrations of IL-6 and IL-8 were found in urine from urothelial carcinoma patients compared to those with benign conditions.
• The combined presence of IL-6 and IL-8 demonstrated high diagnostic accuracy (90.0% sensitivity, 81.25% specificity) for high-grade urothelial carcinoma.
• Receiver operating characteristic analysis supported the utility of IL-6 and IL-8 in differentiating urothelial carcinoma.

Conclusions:

• Urinary IL-6 and IL-8 show promise as non-invasive predictive markers for urothelial carcinoma.
• Further large-scale longitudinal studies are needed to validate these findings and address confounding factors.